Previous 10 | Next 10 |
home / stock / halo / halo articles
It has been about a month since the last earnings report for Kodiak Sciences Inc. (NASDAQ: KOD). Shares have lost about 26.2% in that time frame, u...
These mid-cap stocks were the best performers in the last week. Are they in your portfolio? Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarte...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares are trading higher on the bourses on Thursday after it raised its FY24 guidance. The company sees ...
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Thursday. Shares of The J. M. Smucker Company (NYSE:SJM) rose sha...
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Biophytis posted a FY23 lo...
A new startup, Prophetic, has shown off a new AI-powered headband that promises to help control your dreams and "explore" the subconscious – perh...
Saturday, Bristol Myers Squibb & Co (NYSE:BMY) released the first disclosure of data from the Phase 3 CheckMate -67T trial of the sub...
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis PR Newswire OCREVUS ® subcutaneous (SC) injection offers a new 10-minute administration with comparable effica...
Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy PR Newswire VYVGART® Hytrulo is the first and only neonatal Fc receptor (FcRn) blocker that is delivered as...